Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V J Hruby

Showing results (391-400 of 504) with videos related to

Pageof 51
Sort By:
Molecular and Cellular Endocrinology|February 7, 1997
Characterisation of D117A and H260A mutations in the melanocortin 1 receptorH B Schiöth, R Muceniece, M Szardenings, et al.
Proceedings of the Western Pharmacology Society|January 1, 1990
Evaluation of a food intake model as a tool for studying cholecystokinin (CCK) and derivatives of CCK in male Sprague-Dawley ratsW S Wire, S N Fang, V J Hruby, et al.
Life Sciences|March 23, 1987
Differential structural requirements for the MSH and MCH activities of melanin concentrating hormoneM E Hadley, C Zechel, B C Wilkes, et al.
Peptides|November 26, 1999
The effect of halogenation on blood-brain barrier permeability of a novel peptide drugC L Gentry, R D Egleton, T Gillespie, et al.
International Journal of Peptide and Protein Research|July 1, 1996
Lipid membrane permeability of modified c[D-Pen2, D-Pen5]enkephalin peptidesV Ramaswami, X Zhu, M Romanowski, et al.
Biopharmaceutics & Drug Disposition|April 1, 1997
Skin pigmentation and pharmacokinetics of melanotan-I in humansS O Ugwu, J Blanchard, R T Dorr, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|October 9, 2003
Extensive structure-activity studies of lactam derivatives of MT-II and SHU-9119: their activity and selectivity at human melanocortin receptors 3, 4, and 5P Grieco, P Balse-Srinivasan, G Han, et al.
Pigment Cell Research|October 1, 1991
Biological activities of melanotropic peptide fatty acid conjugatesM E Hadley, F al-Obeidi, V J Hruby, et al.
Journal of Medicinal Chemistry|November 11, 1994
Design, synthesis, and biological properties of highly potent cyclic dynorphin A analogues. Analogues cyclized between positions 5 and 11J P Meyer, N Collins, F D Lung, et al.
European Journal of Pharmacology|October 14, 1994
[N-methylnorleucine-(28,31)]cholecystokinin-(26-33) (SNF 8702) activity at a cloned rat CCKB receptorR J Knapp, E Malatynska, P Peterson, et al.
Pageof 51

Showing results (391-400 of 504) with videos related to

Sort By:
Pageof 51
Molecular and Cellular Endocrinology|February 7, 1997
Characterisation of D117A and H260A mutations in the melanocortin 1 receptorH B Schiöth, R Muceniece, M Szardenings, et al.
Proceedings of the Western Pharmacology Society|January 1, 1990
Evaluation of a food intake model as a tool for studying cholecystokinin (CCK) and derivatives of CCK in male Sprague-Dawley ratsW S Wire, S N Fang, V J Hruby, et al.
Life Sciences|March 23, 1987
Differential structural requirements for the MSH and MCH activities of melanin concentrating hormoneM E Hadley, C Zechel, B C Wilkes, et al.
Peptides|November 26, 1999
The effect of halogenation on blood-brain barrier permeability of a novel peptide drugC L Gentry, R D Egleton, T Gillespie, et al.
International Journal of Peptide and Protein Research|July 1, 1996
Lipid membrane permeability of modified c[D-Pen2, D-Pen5]enkephalin peptidesV Ramaswami, X Zhu, M Romanowski, et al.
Biopharmaceutics & Drug Disposition|April 1, 1997
Skin pigmentation and pharmacokinetics of melanotan-I in humansS O Ugwu, J Blanchard, R T Dorr, et al.
The Journal of Peptide Research : Official Journal of the American Peptide Society|October 9, 2003
Extensive structure-activity studies of lactam derivatives of MT-II and SHU-9119: their activity and selectivity at human melanocortin receptors 3, 4, and 5P Grieco, P Balse-Srinivasan, G Han, et al.
Pigment Cell Research|October 1, 1991
Biological activities of melanotropic peptide fatty acid conjugatesM E Hadley, F al-Obeidi, V J Hruby, et al.
Journal of Medicinal Chemistry|November 11, 1994
Design, synthesis, and biological properties of highly potent cyclic dynorphin A analogues. Analogues cyclized between positions 5 and 11J P Meyer, N Collins, F D Lung, et al.
European Journal of Pharmacology|October 14, 1994
[N-methylnorleucine-(28,31)]cholecystokinin-(26-33) (SNF 8702) activity at a cloned rat CCKB receptorR J Knapp, E Malatynska, P Peterson, et al.
Pageof 51